From:  A simple quantitative model for the prediction of exposure of renally excreted drugs in pregnant women: a comparison with whole body PBPK model

 Fold change in physiological parameters in pregnant women (compared with non-pregnant women) as a function of gestational age

Parameters (fold change)GA 12GA 24GA 30GA 36
V fetoplacental unit*5.6025.6743.5763.43
BF fetoplacental unit*8.0220.1025.2128.17
Ratio (V/BF)0.701.282.192.25
Blood volume*1.081.291.381.43
GFR**1.221.411.511.60
Total body water**1.121.261.321.39
Cardiac output**1.171.331.401.48
Sum5.296.577.88.15
Average1.061.311.561.63

* Parameter data from [16]. V fetoplacental unit: volume of fetoplacental unit. BF fetoplacental unit: blood flow of fetoplacental unit. Ratio: volume of fetoplacental unit/blood flow of fetoplacental unit. ** Parameter data from [7]. Average consists of Ratio (V/BF), total body water, blood volume, cardiac output, and GFR. The final average for the prediction of Cmax and AUC for a gestational age (GA) was with the fraction unbound protein.

The following linear equations were developed to predict the following physiological parameters as a function of gestational age [7]. This was done because the reported physiological parameters [7] did not match with the gestational age used in this study (GA 12, 24, 30, and 36 weeks).

Total body water=0.35×GA+31.4 (r2=0.992)

Cardiac output=3.8×GA+308 (r2=0.982)

GFR=1.8×GA+118 (r2=0.901)

Example

An example of calculation of AUC in pregnant women for digoxin is presented. In order to predict Cmax or AUC for a drug, the fraction unbound protein in plasma will be used as a product characteristic. The fraction unbound protein for digoxin is 0.75. The average for digoxin at GA at week 36 will be 1.48 (average of five ratios in Table 1 plus 0.75 = 1.48). The AUC of digoxin in non-pregnant women was 9.7 ng·hr/mL and in pregnant women in the third trimester or GA 36 weeks, the predicted AUC of digoxin was 9.3/1.48 = 6.3 ng·hr/mL. The observed AUC in pregnant women was 7.3 ng·hr/mL